RapidAI Funding & Investors

RapidAI empowers clinicians to make faster, more accurate diagnostic and treatment decisions for stroke and aneurysm patients. RapidAI's platform uses artificial intelligence to create advanced images from non-contrast CT, CT Angiography, CT perfusion, and MRI diffusion and perfusion scans. It was founded in 2011 and headquartered in Menlo Park, California.